The centre will serve as a hub for the UCL Queen Square Institute of Neurology, the UK Dementia Research Institute at UCL, ...

Hughes’ appointment to the leadership team follows the arrival of James McKnight (CEO), Lawrence Chapman (Group CFO) and ...

Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has achieved more than 80% enrollmentPositive Type C ...

CAE (CAE) announced that after 20 years at CAE, including 15 as President and CEO, and after spearheading the making of CAE as a global leader in training for civil aviation and defence and security ...